ctrl K

Alto Neuroscience Inc. (ANRO)

NYSE: ANRO · Real-Time Price · USD

2.44

-0.01 (-0.41%)

At close: May 02, 2025, 3:59 PM

2.56

4.92%

After-hours: May 02, 2025, 05:05 PM EDT

Alto Neuroscience Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a	210K
Cost of Revenue	n/a	373K	342K	145K
Gross Profit	n/a	-373K	-342K	65K
Operating Income	-68.61M	-37.81M	-29.19M	-12.06M
Interest Income	8.85M	2.35M	114K	2K
Pretax Income	-61.43M	-36.3M	-27.71M	-9.19M
Net Income	-61.43M	-36.3M	-27.71M	-9.19M
Selling & General & Admin	21.61M	7.52M	5.16M	3.75M
Research & Development	47M	30.29M	23.69M	8.37M
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	68.61M	37.81M	28.85M	12.12M
Interest Expense	-1.38M	1.37M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	-342K	-145K
Cost & Expenses	n/a	37.81M	29.19M	12.27M
Income Tax Expense	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	24.6M	26.88M	25.57M	25.57M
Shares Outstanding (Diluted)	24.6M	26.88M	25.57M	25.57M
EPS (Basic)	-2.5	-1.35	-1.08	-0.36
EPS (Diluted)	-2.5	-1.35	-1.08	-0.36
EBITDA	-68.61M	-34.56M	-27.37M	-9.04M
EBIT	-62.81M	-34.94M	-27.71M	-9.08M
Depreciation & Amortization	-5.8M	373K	342K	145K